← Back to Clinical Trials
Recruiting NCT07440927
Stress Urinary Incontinence for Female Patients (CGM MUIT-2301)
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Stress Urinary Incontinence (SUI)
Sponsor Ceragem Clinical Inc.
Study Type INTERVENTIONAL
Phase N/A
Enrollment 96
Sex FEMALE
Min Age 19 Years
Max Age N/A
Start Date 2024-12-13
Completion 2026-09-30
Interventions
Ceragem Innerfit medi-tech
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study is a multicenter, prospective, randomized, double-blind, sham-controlled clinical trial conducted in female patients with stress urinary incontinence.
Eligibility Criteria
Inclusion Criteria: * Patients with urine leakage of ≥1 g on the standardized pad test Exclusion Criteria: * Patients with mixed urinary incontinence with predominant urgency urinary incontinence * Patients with stress urinary incontinence * Patients with overflow urinary incontinence
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology